A 72-year-old woman with CKD stage 4 (eGFR 22 mL/min/1.73 m²) secondary to diabetic nephropathy is being evaluated for mineral and bone disorder (CKD-MBD) management. Which of the following is NOT a recognized mechanism by which hyperphosphatemia accelerates CKD progression and vascular calcification?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.